Total Payments
$16,459
2024 Payments
$4,966
Companies
30
Transactions
400
Medicare Patients
8,275
Medicare Billing
$1.9M
Payment Breakdown by Category
Other$9,750 (59.2%)
Food & Beverage$6,479 (39.4%)
Education$229.97 (1.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $9,750 | 9 | 59.2% |
| Food and Beverage | $6,479 | 387 | 39.4% |
| Education | $229.97 | 4 | 1.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | $8,423 | 30 | $0 (2024) |
| Almatica Pharma LLC | $2,146 | 8 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $1,017 | 84 | $0 (2022) |
| Allergan, Inc. | $723.21 | 59 | $0 (2020) |
| ABBVIE INC. | $718.73 | 37 | $0 (2024) |
| Alkermes, Inc. | $624.11 | 39 | $0 (2021) |
| Neurocrine Biosciences, Inc. | $490.67 | 20 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $324.09 | 16 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $235.70 | 12 | $0 (2024) |
| Shire North American Group Inc | $192.58 | 14 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,966 | 44 | Teva Pharmaceuticals USA, Inc. ($2,272) |
| 2023 | $6,568 | 39 | Teva Pharmaceuticals USA, Inc. ($5,686) |
| 2022 | $787.54 | 40 | Sunovion Pharmaceuticals Inc. ($178.22) |
| 2021 | $700.49 | 37 | AbbVie Inc. ($170.48) |
| 2020 | $860.40 | 51 | Alkermes, Inc. ($183.51) |
| 2019 | $1,036 | 64 | Teva Pharmaceuticals USA, Inc. ($261.15) |
| 2018 | $755.45 | 57 | Allergan Inc. ($242.81) |
| 2017 | $784.83 | 68 | Sunovion Pharmaceuticals Inc. ($328.67) |
All Payment Transactions
400 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $15.70 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 12/18/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $8.57 | General |
| Category: Central Nervous System | ||||||
| 12/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.40 | General |
| Category: NEUROSCIENCE | ||||||
| 12/04/2024 | Almatica Pharma LLC | LOREEV XR (Drug) | Food and Beverage | In-kind items and services | $3.89 | General |
| Category: ANTI-ANXIETY | ||||||
| 11/13/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $18.25 | General |
| Category: NEUROSCIENCE | ||||||
| 11/05/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $22.31 | General |
| Category: PSYCHIATRY | ||||||
| 10/28/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $20.90 | General |
| Category: Central Nervous System | ||||||
| 10/23/2024 | Almatica Pharma LLC | LOREEV XR (Drug) | Food and Beverage | In-kind items and services | $11.83 | General |
| Category: ANTI-ANXIETY | ||||||
| 10/21/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $17.52 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 10/21/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $0.88 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 10/14/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $20.54 | General |
| Category: PSYCHIATRY | ||||||
| 10/02/2024 | Almatica Pharma LLC | LOREEV XR (Drug) | Food and Beverage | In-kind items and services | $10.50 | General |
| Category: ANTI-ANXIETY | ||||||
| 09/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $25.41 | General |
| Category: NEUROSCIENCE | ||||||
| 09/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.55 | General |
| Category: NEUROSCIENCE | ||||||
| 09/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $1.71 | General |
| Category: NEUROSCIENCE | ||||||
| 09/16/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $23.11 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 08/28/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $25.05 | General |
| Category: Neurology | ||||||
| 08/19/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $29.61 | General |
| Category: PSYCHIATRY | ||||||
| 08/15/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $22.65 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 08/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $27.74 | General |
| Category: NEUROSCIENCE | ||||||
| 08/07/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,100.00 | General |
| Category: Neurology | ||||||
| 08/07/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $50.65 | General |
| Category: Neurology | ||||||
| 07/31/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $16.14 | General |
| Category: Neuropsychiatry | ||||||
| 06/24/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $32.39 | General |
| Category: Neuroscience | ||||||
| 06/03/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.97 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 2,137 | 5,213 | $938,061 | $457,126 |
| 2022 | 10 | 1,973 | 5,294 | $785,973 | $455,051 |
| 2021 | 10 | 1,870 | 4,463 | $728,772 | $436,471 |
| 2020 | 12 | 2,295 | 6,502 | $984,953 | $544,489 |
Total Patients
8,275
Total Services
21,472
Medicare Billing
$1.9M
Procedure Codes
41
All Medicare Procedures & Services
41 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 677 | 2,551 | $414,600 | $175,150 | 42.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 500 | 1,195 | $196,086 | $115,027 | 58.7% |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 280 | 361 | $119,011 | $86,389 | 72.6% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2023 | 472 | 690 | $106,826 | $41,777 | 39.1% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2023 | 122 | 122 | $48,800 | $17,335 | 35.5% |
| 90837 | Psychotherapy, 1 hour | Office | 2023 | 19 | 118 | $33,478 | $13,826 | 41.3% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 25 | 93 | $12,580 | $4,988 | 39.7% |
| 90853 | Group psychotherapy | Office | 2023 | 23 | 64 | $3,260 | $1,362 | 41.8% |
| 96116 | Exam of neurobehavioral status, first hour | Office | 2023 | 19 | 19 | $3,420 | $1,273 | 37.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 566 | 2,373 | $284,832 | $163,833 | 57.5% |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2022 | 291 | 384 | $126,593 | $92,918 | 73.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 391 | 828 | $128,340 | $80,852 | 63.0% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2022 | 452 | 722 | $111,779 | $44,131 | 39.5% |
| 90837 | Psychotherapy, 1 hour | Office | 2022 | 45 | 379 | $54,576 | $41,096 | 75.3% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2022 | 119 | 119 | $47,600 | $17,458 | 36.7% |
| 90853 | Group psychotherapy | Office | 2022 | 41 | 376 | $18,900 | $8,039 | 42.5% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 31 | 51 | $5,100 | $2,743 | 53.8% |
| 90832 | Psychotherapy, 30 minutes | Office | 2022 | 13 | 38 | $3,932 | $2,344 | 59.6% |
| 96116 | Exam of neurobehavioral status, first hour | Office | 2022 | 24 | 24 | $4,320 | $1,637 | 37.9% |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2021 | 336 | 536 | $176,703 | $131,747 | 74.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 563 | 1,888 | $226,560 | $127,093 | 56.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 320 | 810 | $125,550 | $81,098 | 64.6% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2021 | 443 | 703 | $108,838 | $43,514 | 40.0% |
| 90837 | Psychotherapy, 60 minutes | Office | 2021 | 59 | 335 | $48,240 | $35,089 | 72.7% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2021 | 70 | 70 | $28,000 | $10,099 | 36.1% |
About Dr. Thomas Andrews, M.D
Dr. Thomas Andrews, M.D is a Psychiatry healthcare provider based in Redding, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1245393651.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Andrews, M.D has received a total of $16,459 in payments from pharmaceutical and medical device companies, with $4,966 received in 2024. These payments were reported across 400 transactions from 30 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($9,750).
As a Medicare-enrolled provider, Andrews has provided services to 8,275 Medicare beneficiaries, totaling 21,472 services with total Medicare billing of $1.9M. Data is available for 4 years (2020–2023), covering 41 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Other Specialties Addiction Psychiatry, Child & Adolescent Psychiatry
- Location Redding, CA
- Active Since 12/18/2006
- Last Updated 10/03/2011
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1245393651
Products in Payments
- UZEDY (Drug) $7,839
- LOREEV XR (Drug) $2,146
- VRAYLAR (Drug) $1,305
- LATUDA (Drug) $1,017
- INGREZZA (Drug) $490.67
- ARISTADA (Drug) $481.38
- AUSTEDO (Drug) $305.09
- REXULTI (Drug) $236.20
- SPRAVATO (Drug) $229.50
- NUEDEXTA (Drug) $170.61
- BELSOMRA (Drug) $164.80
- Aristada 441 mg (Drug) $142.73
- Auvelity (Drug) $130.73
- Austedo XR (Drug) $118.82
- Dayvigo (Drug) $117.04
- QUVIVIQ (Drug) $114.53
- VYVANSE (Drug) $107.00
- CAPLYTA (Drug) $101.99
- UBRELVY (Drug) $96.66
- INVEGA SUSTENNA (Drug) $94.59
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Redding
Ornella Addonizio, M.d, M.D
Psychiatry — Payments: $8,117
Psychiatry $8,117
Aravind Pai, M.d, M.D
Psychiatry — Payments: $2,138
Psychiatry $2,138
Dr. Richard Zarriello, M.d, M.D
Psychiatry — Payments: $1,686
Psychiatry $1,686
Dr. Thomas Swanson, M.d, M.D
Psychiatry — Payments: $482.37
Psychiatry $482.37
Dr. Michael Barberie, M.d, M.D
Psychiatry — Payments: $372.66
Psychiatry $372.66
Dr. Kavitha Raja, M.d, M.D
Psychiatry — Payments: $123.49
Psychiatry $123.49